Case report: Crizotinib is effective in a patient with ROS1-rearranged pulmonary inflammatory myofibroblastic tumor
Author:
Publisher
Elsevier BV
Subject
Cancer Research,Pulmonary and Respiratory Medicine,Oncology
Reference10 articles.
1. Inflammatory myofibroblastic tumour of the lung: a reactive lesion or a true neoplasm?;Panagiotopoulos;J. Thorac. Dis.,2015
2. Crizotinib in ALK(+) inflammatory myofibroblastic tumors-current experience and future perspectives;Theilen;Pediatr. Blood Cancer,2018
3. Drastic initial response and subsequent response to two ALK inhibitors in a patient with a highly aggressive ALK-rearranged inflammatory myofibroblastic tumor arising in the pleural cavity;Ono;Lung Cancer,2016
4. Inflammatory myofibroblastic tumors harbor multiple potentially actionable kinase fusion;Lovly;Cancer Discov.,2014
5. Molecular characterization of inflammatory myofibroblastic tumors with frequent ALK and ROS1 gene fusions and rare novel RET rearrangement;Antonescu;Am. J. Surg. Pathol.,2015
Cited by 26 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Individualized targeted treatment in a case of a rare TFG::ROS1 fusion positive inflammatory myofibroblastic tumor (IMT);Cancer Reports;2023-11-11
2. Development and verification of a newly established cuproptosis-associated lncRNA model for predicting overall survival in uterine corpus endometrial carcinoma;Translational Cancer Research;2023-08
3. Inflammatory myofibroblastic tumors: recent progress and future of targeted therapy;Japanese Journal of Clinical Oncology;2023-07-01
4. Surgical treatment for lung metastasis of inflammatory myofibroblastic tumor of the lung: A case report;Thoracic Cancer;2023-05-05
5. Malignant Mimics of Orphan Lung Diseases;Orphan Lung Diseases;2023
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"全球学者库"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前全球学者库共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2023 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3